Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

OKs For 16 New Drugs But EMA Holds Firm On Betrixaban & Abaloparatide No

Jul 27 2018

• By Maureen Kenny

Related Content

EU Accelerated Assessment Tracker: Rejection Is Standard Outcome For Fast-Track Requests This Year

Jul 25 2018

EU-Wide Restrictions In Store For Bayer's Prostate Cancer Drug

Jul 26 2018

Crunch Time For 18 Products Seeking EU Approval, "No" Stays In Place for Radius

Jul 25 2018

Radius Braced For Second CHMP No For Abaloparatide

Jul 26 2018

EMA ‘Yes’ For Pegfilgrastim Biosimilars Spells End For Neulasta’s EU Stronghold

Jul 27 2018

Additional Topics

Europe Regulation Approvals Drug Review Review Pathway Biosimilars BioPharmaceutical

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window